Ponce, Kyrie Jay .
HRN: 26-46-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/31/2024
01/07/2025
INTRAVENOUS
110 Mg
Every 24 Hours
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes